Revium Rx (RVRC) Interest Expenses (2024 - 2025)
Revium Rx (RVRC) reported Interest Expenses of $2.1 million for Q4 2025, up 67.09% on a YoY basis from $1.3 million in Q4 2024, and up 67.09% sequentially from $1.3 million in Q4 2024.
Revium Rx (RVRC) Interest Expenses (2024 - 2025) Analysis & Trends
Revium Rx (RVRC) has 2 years of Interest Expenses data on file, last reported at $2.1 million in Q4 2025.
- For the quarter ending Q4 2025, Interest Expenses rose 67.09% year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2025 stood at $2.1 million (up 67.09% YoY), and the FY2025 full-year result was $10.7 million, up 717.57% from the prior year.
- Interest Expenses climbed to $2.1 million in Q4 2025, from $1.3 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $2.1 million in Q4 2025 to a low of $1.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | 291.00 Mn |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | 59.56 Mn |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | 25.00 Mn |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | 17.41 Mn |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | 40.00 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | 11.00 Mn |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | 20.68 Mn |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | 616,000.00 |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | 83.30 Mn |
| 10 | Revium Rx | 101.42 Mn | 98.71 Mn | - | 2.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.09 Mn |
| Dec 31, 2025 | 2.09 Mn |
| Dec 31, 2024 | 1.25 Mn |
| Dec 31, 2024 | 1.25 Mn |